What is the current Obesity Intervention Devices market size?

The Obesity Intervention Devices market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Obesity Intervention Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by rising obesity rates.

What are the major challenges facing the Obesity Intervention Devices market?

Challenges include high device costs and limited reimbursement coverage in some regions.

Which regions are expected to lead the Obesity Intervention Devices market?

North America and Europe are expected to dominate the market due to high obesity prevalence.

Who are the top companies in the Obesity Intervention Devices market?

Top companies include Medtronic, Ethicon, and Apollo Endosurgery, offering a range of intervention devices.

What future opportunities exist in the Obesity Intervention Devices market?

Future opportunities include emerging markets and innovative technologies, such as robotic-assisted devices.

How is technology impacting the Obesity Intervention Devices market?

Technological advancements are improving device efficacy and patient outcomes, driving market growth.

What is the current regulatory landscape for Obesity Intervention Devices?

The regulatory landscape is evolving, with increasing scrutiny on device safety and efficacy.

What is the future outlook for the Obesity Intervention Devices market?

The future outlook is positive, with growing demand for effective obesity interventions driving market expansion.

Obesity Intervention Devices - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Obesity Intervention Devices by Application (Hospitals, Gastroenterology clinics, Ambulatory Surgical Centers), by Types (Gastric Bands, Electrical Stimulation System, Gastric Balloon System, Gastric Emptying System, Appetite Suppressors), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Obesity Intervention Devices Market Size | CAGR 10.2 Forecast 2033

Obesity Intervention Devices - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Obesity Intervention Devices Market Overview

The Obesity Intervention Devices market refers to the industry that provides medical devices and equipment designed to treat obesity. As the prevalence of obesity continues to rise globally, the Obesity Intervention Devices market size is estimated to be around $1.4 billion. The growth outlook for this market is promising, with a projected market forecast of $3.5 billion by 2033. The industry expansion is driven by increasing demand for minimally invasive procedures, technological advancements, and rising awareness about obesity-related health issues. The scope of this market encompasses various devices such as gastric bands, gastric balloons, and surgical staplers, among others.

Loading chart…

The Obesity Intervention Devices market is expected to grow at a CAGR of 10.5% during the forecast period, driven by macro drivers such as the increasing prevalence of obesity, rising demand for minimally invasive procedures, and technological advancements. Key forces shaping the industry include technology shifts towards more advanced and minimally invasive devices, regulations and guidelines set by government agencies, and consumer behavior driven by increasing awareness about obesity-related health issues. The largest region in the Obesity Intervention Devices market is North America, while the fastest-growing region is Asia Pacific. The market is expected to witness significant growth in the coming years, driven by the increasing adoption of obesity intervention devices and the growing demand for effective treatment options.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; EnteroMedics; Apollo Endosurgery; Cousin Biotech; Aspire Bariatrics; Obalon Therapeutics; GI Dynamics; Johnson and Johnson; Spatz FGIA; Gore Medical; ReShape Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Obesity Intervention Devices market is experiencing significant growth, driven by increasing prevalence of obesity and related health issues. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting consumer preferences.

Growth Drivers2 items

Advances in minimally invasive procedures are driving the adoption of Obesity Intervention Devices, leading to increased market size and growth forecast. This shift towards less invasive treatments is expected to propel the market forward.

Rising demand for effective weight loss solutions is fueling the growth of the Obesity Intervention Devices market, with manufacturers investing heavily in research and development to cater to this demand.

Restraints2 items

High costs associated with Obesity Intervention Devices are limiting their adoption, particularly in developing economies where healthcare budgets are constrained. This is expected to hinder the market growth forecast.

Stringent regulatory frameworks governing the approval and use of Obesity Intervention Devices are creating barriers to entry for new market players, which may impact the overall market size.

Opportunities2 items

Emerging economies present significant opportunities for Obesity Intervention Devices market growth, driven by increasing healthcare spending and a growing middle class with rising disposable incomes.

The integration of digital technologies with Obesity Intervention Devices is expected to enhance treatment outcomes and improve patient engagement, creating new avenues for market growth and expansion.

Challenges2 items

The Obesity Intervention Devices market faces challenges related to reimbursement and insurance coverage, which can vary significantly across different regions and countries, affecting market size and growth forecast.

Manufacturers must navigate complex supply chain logistics to ensure timely and cost-effective delivery of Obesity Intervention Devices, which can be a significant challenge in certain markets.

Market Segmentation

Loading chart…

The Obesity Intervention Devices market can be segmented based on Application, which includes subtypes such as bariatric surgery and non-invasive fat reduction. This segmentation contributes significantly to the overall Obesity Intervention Devices market size, as it helps in understanding the specific needs of different patient groups and developing targeted solutions. The Application segment plays a crucial role in the Obesity Intervention Devices segmentation, as it enables manufacturers to design and market devices that cater to specific requirements, thereby driving growth in the market.

Another key segment in the Obesity Intervention Devices market is Types, which comprises subtypes such as gastric bands and gastric balloons. This segment is critical in determining the market size, as different types of devices have varying adoption rates and revenue generating potential. By analyzing the Types segment, industry stakeholders can identify areas of opportunity and develop strategies to increase market share, ultimately contributing to the growth of the Obesity Intervention Devices market. Understanding the market taxonomy and Obesity Intervention Devices segmentation is essential for businesses to navigate this complex market and make informed decisions.

Obesity Intervention Devices Segmentation Breakdown10 items

Application

Hospitals

Gastroenterology clinics

Ambulatory Surgical Centers

Types

Gastric Bands

Electrical Stimulation System

Gastric Balloon System

Gastric Emptying System

Appetite Suppressors

Regional Insights

Loading chart…

The Obesity Intervention Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of obesity intervention devices and growing investment in healthcare infrastructure.

Key drivers for each region include: for North America, policies supporting obesity prevention, high ecosystem maturity, and significant demographics affected by obesity; for Europe, infrastructure development, investment in research and development, and adoption of innovative obesity intervention devices; for Asia Pacific, growing demand for obesity treatment options, increasing investment in healthcare, and expanding middle-class demographics; for Latin America, rising awareness about obesity intervention, government initiatives to combat obesity, and improving infrastructure; and for Middle East & Africa, growing prevalence of obesity, investment in healthcare infrastructure, and increasing adoption of obesity intervention devices.

The regional forecast indicates that the Asia Pacific region will experience the highest growth rate, driven by factors such as demographics, infrastructure, and ecosystem maturity. Understanding these regional insights is crucial for stakeholders to navigate the Obesity Intervention Devices market growth and make informed decisions.

Competitive Landscape

The Obesity Intervention Devices market is moderately consolidated, driven by a mix of global players and local companies. The Obesity Intervention Devices competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and customization to cater to specific market needs.

Companies in the Obesity Intervention Devices market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their competitive edge.

Medtronic: regional expansion

EnteroMedics: innovation pipeline

Apollo Endosurgery: premium pricing

Cousin Biotech: local manufacturing

Aspire Bariatrics: OEM tie-ups

Obalon Therapeutics: vertical integration

Key Obesity Intervention Devices Companies11 items

Medtronic

EnteroMedics

Apollo Endosurgery

Cousin Biotech

Aspire Bariatrics

Obalon Therapeutics

GI Dynamics

Johnson and Johnson

Spatz FGIA

Gore Medical

ReShape Lifesciences

Market Ecosystem

The Obesity Intervention Devices ecosystem spans across upstream, midstream, and downstream components, involving various stakeholders who contribute to the development, manufacturing, and delivery of these devices. Technology providers and suppliers form the upstream segment, while integrators and manufacturers constitute the midstream. Channels, including distributors and service providers, facilitate the flow of products to end users, such as healthcare institutions and individual patients, in the downstream segment. The value chain analysis of the Obesity Intervention Devices ecosystem reveals how value is created and captured through the interaction of these stakeholders.

Raw material/component suppliers — provide device components

OEMs / manufacturers — produce intervention devices

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — distribute devices to healthcare institutions

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize intervention devices for patient care

Regulators/standards bodies — establish safety and efficacy standards

The flow of value in the Obesity Intervention Devices ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact the adoption of these devices. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Switching costs, partnerships, and interoperability requirements may vary across different regions, leading to differences in the ecosystem's structure and dynamics. Understanding these factors is crucial for navigating the complex Obesity Intervention Devices ecosystem and identifying opportunities for growth and innovation.

Recent Industry Insights

The Obesity Intervention Devices industry has witnessed significant developments over the last 12-18 months, shaping the future of Obesity Intervention Devices industry trends. Notable partnerships have been formed, such as collaborations between medical device manufacturers and healthcare providers, to enhance the accessibility of obesity intervention solutions. Additionally, there have been key mergers and acquisitions, including the acquisition of smaller device manufacturers by larger industry players, aiming to expand their product portfolios and strengthen their market presence.

Recent product launches have also been observed, with a focus on minimally invasive procedures and advanced technologies like artificial intelligence and data analytics to support personalized treatment plans. Furthermore, regulatory changes have been implemented to ensure the safety and efficacy of obesity intervention devices, while funding rounds have been secured by startups working on innovative solutions, driving growth in the Obesity Intervention Devices industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Obesity Intervention Devices market outlook. The market attractiveness is high, driven by the increasing prevalence of obesity and related health issues. Competitive intensity is moderate, with key players focusing on innovative solutions. The long-term outlook is positive, with growing demand for minimally invasive and non-invasive interventions.

The innovation landscape is evolving, with advancements in bariatric surgery and endoscopic procedures. Demand-supply balance is stable, with manufacturers responding to growing demand. Key risk factors include regulatory hurdles and reimbursement challenges. Overall, the Obesity Intervention Devices market outlook is promising, with opportunities for growth and innovation.

11 items

1. Executive Summary

2. Obesity Intervention Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Obesity Intervention Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Gastroenterology clinics

6.1.3. Ambulatory Surgical Centers

6.2. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gastric Bands

6.2.2. Electrical Stimulation System

6.2.3. Gastric Balloon System

6.2.4. Gastric Emptying System

6.2.5. Appetite Suppressors

6.3. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Obesity Intervention Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Obesity Intervention Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Obesity Intervention Devices Market Competition by Key Manufacturers

8.1. Global Obesity Intervention Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Obesity Intervention Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. EnteroMedics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Apollo Endosurgery

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cousin Biotech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aspire Bariatrics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Obalon Therapeutics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GI Dynamics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Johnson and Johnson

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Spatz FGIA

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Gore Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ReShape Lifesciences

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Obesity Intervention Devices Market

Figure 4: Global Obesity Intervention Devices Market: Drivers

Figure 5: Global Obesity Intervention Devices Market: Challenges

Figure 6: Global Obesity Intervention Devices Market: Trends

Figure 7: Global Obesity Intervention Devices Market: Opportunity

Figure 8: Global Obesity Intervention Devices Market: Restraint

Figure 9: Global Obesity Intervention Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Obesity Intervention Devices Market Value (USD Million) By Region

Figure 15: Global Obesity Intervention Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Obesity Intervention Devices Market Value (USD Million) By Region

Figure 23: Global Obesity Intervention Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Obesity Intervention Devices Market Value (USD Million) By Region

Table 10: Global Obesity Intervention Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Obesity Intervention Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Obesity Intervention Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Obesity Intervention Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: EnteroMedics Basic Information And Sales Area

Table 33: EnteroMedics. Products Portfolio

Table 34: Apollo Endosurgery Basic Information And Sales Area

Table 35: Apollo Endosurgery. Products Portfolio

Table 36: Cousin Biotech Basic Information And Sales Area

Table 37: Cousin Biotech. Products Portfolio

Table 38: Aspire Bariatrics Basic Information And Sales Area

Table 39: Aspire Bariatrics. Products Portfolio

Table 40: Obalon Therapeutics Basic Information And Sales Area

Table 41: Obalon Therapeutics. Products Portfolio

Table 42: GI Dynamics Basic Information And Sales Area

Table 43: GI Dynamics. Products Portfolio

Table 44: Johnson and Johnson Basic Information And Sales Area

Table 45: Johnson and Johnson. Products Portfolio

Table 46: Spatz FGIA Basic Information And Sales Area

Table 47: Spatz FGIA. Products Portfolio

Table 48: Gore Medical Basic Information And Sales Area

Table 49: Gore Medical. Products Portfolio

Table 50: ReShape Lifesciences Basic Information And Sales Area

Table 51: ReShape Lifesciences. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Obesity Intervention Devices Market Value (USD Million) By Region

Table 57: Global Obesity Intervention Devices Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Obesity Intervention Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; EnteroMedics; Apollo Endosurgery; Cousin Biotech; Aspire Bariatrics; Obalon Therapeutics; GI Dynamics; Johnson and Johnson; Spatz FGIA; Gore Medical; ReShape Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options